Pfizer: High Yield and Solid Cash Flow but a Patent Cliff Looms — A Tactical Long
Pfizer offers a compelling mix of yield, cash generation and near-term pipeline excitement (notably berobenatide for weight loss) that supports a tactical long. The stock trades near $27 with a market cap of about $153B, pays a 6.4% yield and generates roughly $11B in free cash flow — metrics that matter for income-minded traders. That said, materi…